| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/02/2004 | US20040243051 for oxygenating blood; inlet for receiving deoxygenated blood and transporting to a photolytic cell having a photoreactive surface to convert water in the blood to dissolved oxygen; light activated catalyst is anatase (TiO2), WO3 or ZnO |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin |
| 12/02/2004 | US20040242480 Method for treating coumarin-induced hemorrhage |
| 12/02/2004 | US20040242469 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| 12/02/2004 | US20040242466 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 12/02/2004 | US20040241838 Reprograming/dedifferentiating somatic cell nucleus via propagation in nutrient broth comprising nuclear factors and soluble components of cytoplasm; tissue engineering and transplantation; generating mammalian pluripotent stem cells from somatic tissue; remodeling somatic nuclei; organ development model |
| 12/02/2004 | US20040241837 Methods for forming normal regenerated tissues, the normal regenerated tissues, and method of calibrating sensitivity and so on |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241825 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241784 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
| 12/02/2004 | US20040241772 Solid composition cantaining bacillus-type non-pathogenic bacterial spores |
| 12/02/2004 | US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241260 Menopause therapy; mixture of flavonoids and Lactobacillus |
| 12/02/2004 | US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids |
| 12/02/2004 | US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents |
| 12/02/2004 | US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection |
| 12/02/2004 | US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus |
| 12/02/2004 | US20040241170 Fetal Antigen-1 (FA1/dlk1) gene expression/inhibition; populations enriched in dopaminergic neurons, neural progenitor cells or neural stem cells, for ex-vivo gene therapy; drug screening/design |
| 12/02/2004 | US20040241167 CD4/CD25 antigen containing cell, interleukin, CD8/CD28 antigen containing cell, and vitamin D3; for generating tolerogenic antigen-presenting cell; kits; for treatment of autoimmune diseases such as AIDS, cancer, and Hepatitis C-related disorders |
| 12/02/2004 | US20040241162 Activation and expansion of cells |
| 12/02/2004 | US20040241153 Methods of generating human cd4+ th1 cells |
| 12/02/2004 | US20040241151 hydrophilic polymer films or laminates, that are nontoxic and nonirritating to skins and mucous membranes containing strains of pediococcus, lactococcus, lactobacillus or mixtures; storage stability; hygiene products |
| 12/02/2004 | US20040241150 Defined competitive exclusion cultures for food borne pathogens |
| 12/02/2004 | US20040241149 prevention or prophylaxis of inflammatory condition comprising administering lactic acid bacteria containing unmethylated cytosine-guanine (cpg) dinucleotide to modulate the cytokine response of human or animal immune system; antiinflammatory agents |
| 12/02/2004 | US20040241147 antigen presenting cells which express major histocomatibility complexes, used as vaccines |
| 12/02/2004 | US20040241146 drug delivery; surgery; preventin post-operative scaring |
| 12/02/2004 | US20040241145 adhesion of mesenchymal stem cells or osteoblasts to fibers and/or porometric material which can serve as biological scaffold for the cells; tissue engineering |
| 12/02/2004 | US20040241144 mixing of synovial fluid and mesenchymal cells for use in tissue engineering; prophylaxis of degenerative joint diseases |
| 12/02/2004 | US20040241142 Vectors; human promoter coupling to gene; kill ing cancer cells |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | CA2528521A1 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | CA2526478A1 Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same |
| 12/02/2004 | CA2526475A1 Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| 12/02/2004 | CA2526470A1 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| 12/02/2004 | CA2526432A1 Self-contained heating unit and drug-supply unit employing same |
| 12/02/2004 | CA2526158A1 A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survivalproperty, intestinal binding property, an infection protection property and a fiber fermenting property |
| 12/02/2004 | CA2525519A1 Generation and isolation of antigen-specific t cells |
| 12/02/2004 | CA2525304A1 Recombinant gene medicine of adenovirus vector and gene p53 for treating proliferative diseases |
| 12/02/2004 | CA2431080A1 Enhancement of anticancer immunity through inhibition of arginase |
| 12/01/2004 | EP1482030A1 Method for increasing the yield of proliferating primary keratinocytes |
| 12/01/2004 | EP1481989A1 A-33 related antigens and their pharmacological uses |
| 12/01/2004 | EP1481682A1 Preparation that contains oligosaccharides and probiotics |
| 12/01/2004 | EP1481681A1 Lactic acid bacteria combination and compositions thereof |
| 12/01/2004 | EP1481676A1 Phytoestrogens and probiotic for women's health |
| 12/01/2004 | EP1481243A1 Therapeutic properties of oils |
| 12/01/2004 | EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 12/01/2004 | EP1481055A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 12/01/2004 | EP1480682A1 Coupling proteins to a modified polysaccharide |
| 12/01/2004 | EP1480669A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 12/01/2004 | EP1480667A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
| 12/01/2004 | EP1480661A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics |
| 12/01/2004 | EP1480656A1 Hyaluronic acid mediated adenoviral transduction |
| 12/01/2004 | EP1480646A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 12/01/2004 | EP1480610A1 Use of a hsp inducing compound to limit secondary effects of retinoids |
| 12/01/2004 | EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 12/01/2004 | EP1435787A4 Nestin-expressing hair follicle stem cells |
| 12/01/2004 | EP1379139A4 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 12/01/2004 | EP1212428B1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 12/01/2004 | EP1139784B1 Food-induced antisecretory proteins in egg yolk |
| 12/01/2004 | EP1073443B1 Method for preparing a diafiltered stabilized blood product |
| 12/01/2004 | EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 12/01/2004 | CN1551783A Method for treating multiple myeloma |
| 12/01/2004 | CN1551782A Chimeric flavivirus vectors |
| 12/01/2004 | CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles |
| 12/01/2004 | CN1551728A Production of transduced hematopoietic progenitor cells |
| 12/01/2004 | CN1550545A Method of producing lactic bacteria and killed lactic bacterial cells belonging to the enterococcus |
| 12/01/2004 | CN1550160A Alkaline mineral matter solution ,its preparation method and food for preventing osteoporosis using it |
| 12/01/2004 | CN1177934C Adneovirus-mediated intratumoral delivery of angiogenesis antagonist for treatment of tumors |
| 12/01/2004 | CN1177863C Attenuated microorganisms for treatment of infection |
| 12/01/2004 | CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
| 12/01/2004 | CN1177609C Medicine for curing sleepless |
| 12/01/2004 | CN1177607C Pile-treating Chinese medicine |
| 12/01/2004 | CN1177606C Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
| 12/01/2004 | CN1177601C Medicine for treating scald and its preparing method |
| 12/01/2004 | CN1177600C Chinese medicine compound preparation for treating cervical spondylosis, and preparing process thereof |
| 12/01/2004 | CN1177599C Chinese medicine for treating burn and scald and its preparing process |
| 12/01/2004 | CN1177597C Nose drops for rhinitis |
| 12/01/2004 | CN1177591C Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 11/30/2004 | US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease |
| 11/30/2004 | US6825031 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance |
| 11/30/2004 | US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 11/30/2004 | US6824561 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 11/25/2004 | WO2004101776A2 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 11/25/2004 | WO2004101775A1 Novel stem cell derived from adult tissue and use thereof |
| 11/25/2004 | WO2004101772A2 Neural cells |
| 11/25/2004 | WO2004101770A1 Antioxidant producing bacterium and uses thereof |
| 11/25/2004 | WO2004101762A2 Detection and treatment of cancers of the colon |
| 11/25/2004 | WO2004100974A1 USE OF Hab 18G/CD 147 MOLECULE AS TARGET OF ANTIVIRAL ANTAGONIST AND THUS OBTAINED ANTIVIRAL ANTAGONIST |
| 11/25/2004 | WO2004100967A2 Preparation containing animal bile |
| 11/25/2004 | WO2004100877A2 Vaccine accelerator factor (vaf) for poultry |
| 11/25/2004 | WO2004100866A2 Alcohol-free transdermal analgesic composition |
| 11/25/2004 | WO2004100860A2 Stable liposomes for microencapsulation of animal venoms |
| 11/25/2004 | WO2004100833A1 Method of sowing cell |
| 11/25/2004 | WO2004100831A1 Method of removing cell |
| 11/25/2004 | WO2004100773A2 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 11/25/2004 | WO2004091637A3 System capable of treating and defining various diseases using stem cells |